<DOC>
	<DOCNO>NCT01516892</DOCNO>
	<brief_summary>This open-label study ass long-term efficacy , safety , tolerability onabotulinumtoxinA administer prophylaxis headache patient chronic migraine .</brief_summary>
	<brief_title>A Long-term Efficacy , Safety , Tolerability Study BOTOX® Patients With Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Diagnosis chronic migraine ( ≥15 day per month headache last 4 hour day longer ) Diagnosis myasthenia gravis , EatonLambert Syndrome , amyotrophic lateral sclerosis Headache attribute another disorder Infection skin disorder injection sit Previous treatment botulinum toxin serotype reason Anticipated need botulinum toxin type reason course study Previous participation botulinum toxin clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>